Enjoy the replay of #aictPCR session about Complications, with our CERC and CERC Asia experts! 👉 https://bit.ly/2WvInvG...
The ABILITY Diabetes Global study comparing the ABLUMINUS Sirolimus eluting stent from Concept Medical to the XIENCE Everolimus Eluting stent from Abbott Vascular in diabetic patients is conducted in transatlantic cooperation between CERC and Icahn School of Medicine at Mount Sinai (NY, USA). Patient inclusion has recently begun, reaching enrollment of the first 100 patients out of a total of 3000 patients in early November. Read more about this trial...
Our CERC Chronicle has just been published. SCOPE 2, our Corelab services, e-visits, ABILITY DG… what’s up at CERC ?...
CERC is very proud of its Corelab Manager Antoinette Neylon who participated in PCR Valves e-course opening ceremony! At PCR Valves was also presented a CERC trial,...
CERC has developped its own highly secured and perfectly efficient e-Visits tool, in order to achieve e-visits with complete confidence. This new tool offers the same high-quality of data verification& site support as on-site monitoring visits. Our e-Visits system is part a comprehensive e-tools kit that enables CERC to manage remotely each of its studies. Want to know more about our eTools and remote process ? Contact...
Database was successfully locked on August 7th, 2020! The long-awaited results of the SCOPE II study will be presented during the late breaking trial session by Prof. Corrado Tamburino at TCT Connect on Thursday, October 15th at 5pm. Join the session The results are published in Circulation 👉 CLICK...
